Status:

COMPLETED

Infant Behavioral Sleep Intervention: Comparative Efficacy

Lead Sponsor:

Indiana University

Collaborating Sponsors:

Purdue University

Saint-Joseph University

Conditions:

Insomnia

Eligibility:

All Genders

6-18 years

Phase:

NA

Brief Summary

While frequent night awakenings in newborns are common and expected, an estimated 20-30% of older infants and toddlers have frequent problematic night wakings requiring parental intervention throughou...

Detailed Description

Study Design: Randomized controlled trial (RCT). Approximately thirty participants will be randomized to a control condition or one of two intervention conditions. Participants: Participants are heal...

Eligibility Criteria

Inclusion

  • Infant has disruptive night wakings (wakes 1x or more/night, 5+ nights per wk; caregiver intervenes at night wakings)
  • Infant is placed in bed asleep in a crib/bassinet or similar at bedtime at least five nights per week
  • Parent/caregiver goal is for the infant to fall asleep independently at bedtime and/or return to sleep independently during the night
  • Parent/caregiver goal is for the infant to sleep in crib or similar
  • Parent/caregiver lives in the home with the infant, is typically at home at the time of the infant's typical bedtime at least 5 nights a week, and is primary caregiver at bedtime and during the night.
  • The family must have in-home private wireless access that they are willing to share with the study team (necessary for streaming video)
  • Families lives in Indianapolis, Indiana or surrounding areas (within 50 miles of Indiana University School of Medicine)

Exclusion

  • Infant has a chronic major medical condition that affects sleep
  • Infant has a major developmental condition (e.g. Down syndrome)
  • Family is already receiving professional help for the infant's sleep problems
  • Infant snores 5+ nights per week (in which case a sleep study will be recommended; families could participate in the study following a negative sleep study.)
  • Infant has chronic skin conditions (e.g. eczema) that would prohibit wearing an actigraph on the leg

Key Trial Info

Start Date :

February 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 10 2019

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03447665

Start Date

February 1 2018

End Date

April 10 2019

Last Update

April 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University School of Medicine

Indianapolis, Indiana, United States, 46202